Taiwan FDA registration 2ba597d15b1e5f7d220599ebb21561db

Abbott urine/cerebrospinal fluid protein correction group

TW: 亞培尿液/腦脊髓液蛋白質校正液組
Taiwan flagTaiwan·Risk Class 2·FISHER DIAGNOSTICS, A DIVISION OF FISHER SCIENTIFIC COMPANY, LLC, A PART OF THERMO FISHER SCIENTIFIC INC.;; ABBOTT GMBH·Registered Jan 29, 2019 – Jan 29, 2029Active
Registration details
Analysis ID
2ba597d15b1e5f7d220599ebb21561db
Customs Code
DHA05603214902
Company information
Manufacturer Country
United States;;Germany
Product details
Intended Use
Calibration of urine/cerebrospinal fluid protein test using Alinity c analyzer.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1150 Calibrated Products
Import Information
Contract manufacturing;; input
Dates and status
Registration Date
Jan 29, 2019
Expiry Date
Jan 29, 2029
About this record

Access comprehensive regulatory information for Abbott urine/cerebrospinal fluid protein correction group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2ba597d15b1e5f7d220599ebb21561db and manufactured by FISHER DIAGNOSTICS, A DIVISION OF FISHER SCIENTIFIC COMPANY, LLC, A PART OF THERMO FISHER SCIENTIFIC INC.;; ABBOTT GMBH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices